Home
>
US Stocks
>
Phathom Pharmaceuticals Inc
Phathom Pharmaceuticals Inc
PHAT

Phathom Pharmaceuticals Inc (PHAT)

$29.449.11%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
30.13
Today Low/High
29.04 / 30.13
52 Week Low/High
$29.79 / $50.78
Market Cap
$993.37M

Company Details

Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders.
Organisation
Phathom Pharmaceuticals Inc
Employees
55
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Phathom Pharmaceuticals Inc (PHAT) share price today?

Can Indians buy Phathom Pharmaceuticals Inc (PHAT) shares?

How can I buy Phathom Pharmaceuticals Inc (PHAT) shares from India?

Can Fractional shares of Phathom Pharmaceuticals Inc (PHAT) be purchased?

What are the documents required to start investing in Phathom Pharmaceuticals Inc (PHAT) stocks?

We are a SEBI registered investement advisor